Pharmacy Times

JUNE 10, 2025

Seminars in Arthritis and Rheumatism. Related Videos Related Content Advertisement June 10th 2025 Inpatient Biosimilar Use Grows, Offering Cost-Saving Opportunities for Health Systems Aislinn Antrim, Managing Editor June 3rd 2025 S2. Meloxicam: Selective COX-2 inhibition in clinical practice. December 21, 2004. Subscribe Now!

Pharmacy Technician 29

Pharmacy Technician HIV Treatment and Prevention Agents Compounding Pharmacies Biosimilars 29

Pharmacy Times

JULY 10, 2025

News All News FDA Updates Press Releases Media All Videos Digital Detail Independent Corner Insights Interviews MEDcast Medical World News Microsites Peer Exchange Perfect Consult Podcasts Practice Pearls Sponsored Webcast Student Voices Webinars/Webcasts Conferences Conference Coverage Conference Listing Publications Pharmacy Times Pharmacy Practice (..)

Pharmacy Technician 26

Pharmacy Technician Immunity Immunization Specialty Pharmacies 26

Pharmacy Times

JUNE 19, 2025

Coenzyme Q10 for patients with cardiovascular disease: JACC focus seminar. The effect of folic acid in patients with cardiovascular disease: a systematic review and meta-analysis. Medicine (Baltimore). 2019;98(37):e17095. doi:10.1097/MD.0000000000017095 0000000000017095 9. Raizner AE, Quiñones MA. J Am Coll Cardiol. 2021;77(5):609-619.

Pharmacy Technician 26

Pharmacy Technician Compounding Pharmacies Diabetes Hospitals 26

Pharmacy Times

JUNE 6, 2025

I did not understand what she meant until after I completed my fall seminar. My preceptor said, “[Because] you finished your fall seminar, your goal this weekend is to take a break for a day and to take some time to celebrate your accomplishment.”

Pharmacy Technician 48

Pharmacy Technician Compounding Pharmacies Pharmacy Management Hospitals 48

FDA Law Blog: Biosimilars

JANUARY 11, 2024

This day-long (FREE) seminar is a must-attend event for anyone in the pharmaceutical sector interested in understanding the “ins and outs” of doing business in the Territory, as well as an opportunity to interact with those who already have a keen understanding of doing business in Puerto Rico.

Controlled Substances 59

Controlled Substances 59

pharmaphorum

SEPTEMBER 28, 2020

Professor Mohamad Mohty, head of haematology and cellular therapy at Saint-Antoine Hospital, told the webinar audience: “It is really amazing to see the number of haematology indications, whether for new molecular entities or for biosimilars.”. Data from the US cited during the webinar showed a five-year survival rate of 34.2%

Biosimilars 105

Biosimilars Hospitals 105